Quarterly report pursuant to Section 13 or 15(d)

Note Purchase Agreement (Details Narrative)

v3.22.2.2
Note Purchase Agreement (Details Narrative) - USD ($)
3 Months Ended 9 Months Ended
Oct. 09, 2022
Apr. 19, 2022
Dec. 14, 2021
Sep. 30, 2022
Sep. 30, 2022
Sep. 30, 2021
Dec. 31, 2021
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Contingent stock liability         $ 677,000
Contingent warrants liability         $ 585,000
Common stock, shares issued       9,207,415 9,207,415   5,187,062
Fair value adjustment of warrants         $ 228,655    
Exercise price $ 5.32            
Warrant liability       $ 3,101,102 3,101,102  
Note Warrant [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Fair value adjustment of warrants       $ 16,870 $ 75,295    
Exercise price         $ 4.25    
Note Purchase Agreement [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Interest rate       8.00% 8.00%    
Contingent stock liability     $ 677,000        
Contingent warrants liability     585,000        
Allocation of debt issuance cost to contingent stock and contingent warrants     124,460        
Notes payable       $ 665,000 $ 665,000    
Debt discount       1,335,000 1,335,000    
Interest expense         39,111  
Accreted interest       1,299,895 1,299,895  
Notes payable         2,000,000    
Common stock, shares issued   235,295          
Fair value adjustment of warrants   $ 496,000          
Note Purchase Agreement [Member] | Note Warrant [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Fair value adjustment of warrants         $ 502,648    
Contingent warrant         235,295    
Exercise price         $ 4.25    
Warrant liability       $ 82,352 $ 82,352   $ 585,000
Note Purchase Agreement [Member] | Unrelated Third Party Purchasers [Member]              
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]              
Debt instrument face amount     $ 2,000,000        
Interest rate     8.00%        
Debt description     As additional consideration to the Purchasers for providing the financing, the Company also agreed to a) issue each Purchaser a number of shares of the Company’s Common Stock equal to 50% of the original principal amount each Purchaser’s Note (the “Contingent Stock”) and b) issue each Purchaser a number of warrants, which would allow the Purchasers to purchase additional shares of the Company’s Common Stock, equal to 50% of the original principal amount each Purchaser’s Note for a term of 5.0 years (the “Contingent Warrants”)        
Debt issuance costs     $ 197,500